Arizona Prescription Monitoring Program
The Arizona Prescription Monitoring Program (PMP), housed in the Arizona State Board of Pharmacy, collects data on all controlled substance prescriptions in Arizona (schedules II-V). This information assists healthcare providers in making better-informed care decisions when treating patients. The PMP also helps prevent the diversion and misuse of controlled substances at the provider, pharmacy, and patient levels. For more information about the PMP, please click here.
Latest Updates
-
The requirement to report naloxone dispensations to the CSPMP removed! - Effective June 21, 2024 - Chaptered Version - Fact Sheet
-
Cyberattack: EPCS/Surescripts and Change Healthcare - FAQ: Change Healthcare Cyberattack / EPCS Update
-
Bamboo Health offering updated CSPMP AWARxE Support Center
- New FAQ Available: Over-the-counter (“OTC”) Naloxone Approved by FDA
- OPIOID MONITORING INITIATIVE - Xylazine – An Emerging Drug Threat
- DATA-Waiver Program eliminated by Congress- For details, please see this announcement from the Department of Justice/DEA.
- CMS to Require Electronic Prescribing for Controlled Substances Covered Through Medicare Part D Beginning January 1, 2023
- CDC Releases UPDATED Clinical Practice Guideline for Prescribing Opioids for Pain
- Providers Must Be Registered With the Prescription Monitoring Program With All Active DEA Numbers
Hot Topics
The 2024 Arizona CSPMP Survey is Available Now!
The Arizona Controlled Substances Prescription Monitoring Program (CSPMP) conducts an annual survey to gather feedback on the program. To help us improve the program, we hope you take a few minutes to complete the survey. Your responses will be anonymous and kept confidential. The CSPMP team will use the survey results to enhance the program, so your input is valuable. Thank you for your assistance!